Efficacy and safety of Amtolmetin Guacyl in the symptomatic treatment of the osteoarthritis

Abstract Views: 956
PDF: 683
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Forty-two patients affected by osteoarthritis have been treated with two parallel schemes, in double blind, according to parallel groups, to have a correct evaluation of the efficacy and safety of Amtolmetin Guacyl administration on at full stomach or empty stomach. As parameters of efficacy the spontaneus pain and the pain caused by movements, the function and joint pain have been considered, while gastric tolerance has been evaluated by means of daily records made by patients and the general tolerance through an annotation of adverse events, vital signs as well as parameters of laboratory. The drug worked for both groups, but it has been particulary efficent in those who have assumed the drug on a empty stomach. The general tolerance has been good and some adverse side effects, concerning the gastric tolerance, have disappeared by reducing the dosage of the drug. As a result of this study we can assume that amtolmetin guacyl is much more efficent when it is assumed on a empty stomach, with its conseguent advantages in terms of compliance and its possible utilization in case of need.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

How to Cite

Biasi, G., Moltoni, L., Acciai, C., Di Martino, S., & Marcolongo, R. (2001). Efficacy and safety of Amtolmetin Guacyl in the symptomatic treatment of the osteoarthritis. Reumatismo, 53(2), 145–150. https://doi.org/10.4081/reumatismo.2001.145